M. Cameron

发表

Development of Functionally Selective, Small Molecule Agonists at Kappa Opioid Receptors*

A. M. Phillips, L. Bohn, Lei Zhou, 2013, The Journal of Biological Chemistry.

Evaluation of Platensimycin and Platensimycin-Inspired Thioether Analogues against Methicillin-Resistant Staphylococcus aureus in Topical and Systemic Infection Mouse Models.

B. Shen, Lin Qiu, M. Cameron, 2019, Molecular pharmaceutics.

Synthesis and SAR of Lehualide B: a marine-derived natural product with potent anti-multiple myeloma activity.

J. Cleveland, M. Cameron, Valer Jeso, 2013, ACS chemical biology.

Precise small-molecule recognition of a toxic CUG RNA repeat expansion.

M. Disney, R. Yasuda, D. Furling, 2017, Nature chemical biology.

Synthesis of benzoquinone ansamycin-inspired macrocyclic lactams from shikimic acid.

P. Lograsso, M. Cameron, Hajeung Park, 2013, Angewandte Chemie.

Oxidative Metabolism as a Modulator of Kratom's Biological Actions.

Samuel T. Slocum, G. Pasternak, J. Pintar, 2021, Journal of medicinal chemistry.

Cytochrome P450-Mediated Bioactivation of the Epidermal Growth Factor Receptor Inhibitor Erlotinib to a Reactive Electrophile

M. Cameron, Xiaohai Li, T. Kamenecka, 2010, Drug Metabolism and Disposition.

Design and synthesis of 1-aryl-5-anilinoindazoles as c-Jun N-terminal kinase inhibitors.

M. Cameron, T. Kamenecka, Y. Shin, 2013, Bioorganic & medicinal chemistry letters.

JNK Inhibition Protects Dopamine Neurons and Provides Behavioral Improvement in a Rat 6-hydroxydopamine Model of Parkinson's Disease.

G. Robertson, P. Lograsso, M. Cameron, 2011, ACS chemical neuroscience.

Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) inhibitors.

P. Lograsso, M. Cameron, Y. Ling, 2011, Bioorganic & medicinal chemistry letters.

Synthesis and SAR of 4-(pyrazol-3-yl)-pyridines as novel c-jun N-terminal kinase inhibitors.

P. Lograsso, M. Cameron, Y. Ling, 2011, Bioorganic & medicinal chemistry letters.

Synthesis and SAR of 2-phenoxypyridines as novel c-Jun N-terminal kinase inhibitors.

M. Cameron, T. Kamenecka, Claudia H. Ruiz, 2011, Bioorganic & medicinal chemistry letters.

Hydrocarbon-stitched Peptide Agonists of Glucagon-Like Peptide-1 Receptor.

N. Danial, Marina Godes, L. Walensky, 2020, ACS chemical biology.

Discovery of Selective Inhibitors for In Vitro and In Vivo Interrogation of Skeletal Myosin II.

G. Rumbaugh, P. Griffin, J. Sellers, 2021, ACS chemical biology.

Discovery of a Novel, Selective and Short-Acting Skeletal Myosin II Inhibitor

G. Rumbaugh, P. Griffin, J. Sellers, 2020, bioRxiv.

In vivo instability of platensimycin and platencin: Synthesis and biological evaluation of urea- and carbamate-platensimycin.

B. Shen, M. Cameron, Claudia H. Ruiz, 2017, Bioorganic & medicinal chemistry.

Synthesis of conolidine, a potent non-opioid analgesic for tonic and persistent pain.

L. Bohn, K. Raehal, J. Streicher, 2011, Nature chemistry.

Selective and Brain Penetrant Neuropeptide Y Y2 Receptor Antagonists Discovered by Whole-Cell High-Throughput Screening

C. Wahlestedt, T. Spicer, S. Brothers, 2010, Molecular Pharmacology.

Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) Biodegradation in Liquid and Solid-State Matrices by Phanerochaete chrysosporium

M. Cameron, B. Aken, S. Aust, 2001 .

Discovery of small-molecule enzyme activators by activity-based protein profiling

D. Boger, D. Wolan, B. Cravatt, 2020, Nature Chemical Biology.

Albumin-Oxanorbornadiene Conjugates Formed ex Vivo for the Extended Circulation of Hydrophilic Cargo.

M. Finn, M. Cameron, Marsha R. Eno, 2016, ACS chemical biology.

Fungi, for Biotechnology

M. Cameron, S. Aust, N. S. Reading, 2003 .

A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response

Andrew L. Kung, Matthew D. Wilkerson, Michael D. Cameron, 2012, Nature.

Synthesis, biological evaluation, X-ray structure, and pharmacokinetics of aminopyrimidine c-jun-N-terminal kinase (JNK) inhibitors.

P. Lograsso, J. Habel, M. Cameron, 2010, Journal of medicinal chemistry.

D-amino acid based protein arginine deiminase inhibitors: Synthesis, pharmacokinetics, and in cellulo efficacy.

Xiangli Cui, A. Chumanevich, L. Hofseth, 2012, ACS medicinal chemistry letters.

Structure-Activity Relationship and Biological Investigation of SR18292 (16), a Suppressor of Glucagon-Induced Glucose Production.

P. Puigserver, P. Griffin, K. Sharabi, 2021, Journal of medicinal chemistry.

Tetrahydroisoquinoline derivatives as highly selective and potent Rho kinase inhibitors.

P. Lograsso, S. Schürer, J. Pocas, 2010, Journal of medicinal chemistry.

Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation

Callen T. Wallace, Simon C Watkins, G. M. Wilson, 2018, PLoS biology.

Selective Targeting of Extracellular Insulin-Degrading Enzyme by Quasi-Irreversible Thiol-Modifying Inhibitors.

Hui Wang, S. Schürer, M. Leissring, 2015, ACS chemical biology.

Discovery and optimization of indoles and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-I).

P. Lograsso, S. Schürer, J. Pocas, 2011, Bioorganic & medicinal chemistry letters.

Synthesis and biological evaluation of 4-quinazolinones as Rho kinase inhibitors.

P. Lograsso, J. Pocas, Yan Yin, 2011, Bioorganic & medicinal chemistry letters.

The development of benzimidazoles as selective rho kinase inhibitors.

P. Lograsso, J. Pocas, Yan Yin, 2010, Bioorganic & Medicinal Chemistry Letters.

Benzimidazole- and benzoxazole-based inhibitors of Rho kinase.

P. Lograsso, S. Schürer, J. Pocas, 2008, Bioorganic & medicinal chemistry letters.

Chroman-3-amides as potent Rho kinase inhibitors.

P. Lograsso, S. Schürer, M. Cameron, 2008, Bioorganic & medicinal chemistry letters.

Full Pharmacological Efficacy of a Novel S1P1 Agonist That Does Not Require S1P-Like Headgroup Interactions

Steven J Brown, P. Gonzalez-Cabrera, M. Sanna, 2008, Molecular Pharmacology.

Characterization of T-5 N -Oxide Formation as the First Highly Selective Measure of CYP3A5 Activity

G. S. Walker, S. Heyward, M. Cameron, 2014 .

Cooperative binding of acetaminophen and caffeine within the P450 3A4 active site.

W. Atkins, M. Cameron, A. Roberts, 2007, Chemical research in toxicology.

Small molecule 1a reduces FMRpolyG-mediated toxicity in in vitro and in vivo models for FMR1 premutation

M. Disney, R. Willemsen, M. Cameron, 2021, Human molecular genetics.

Promoting activity of (α4)3(β2)2 nicotinic cholinergic receptors reduces ethanol consumption

J. Lindstrom, A. Kuryatov, Jingyi Wang, 2019, Neuropsychopharmacology.

A G protein signaling-biased agonist at the μ-opioid receptor reverses morphine tolerance while preventing morphine withdrawal

L. Bohn, Edward L. Stahl, Cullen L. Schmid, 2019, Neuropsychopharmacology.

Optimization of a Series of Mu Opioid Receptor (MOR) Agonists with High G Protein Signaling Bias.

L. Bohn, K. Lovell, Cullen L. Schmid, 2018, Journal of medicinal chemistry.

Identification of an aminothiazole series of RORβ modulators.

Ruben D. Garcia-Ordonez, P. Griffin, M. Cameron, 2018, Bioorganic & medicinal chemistry letters.

Disubstituted piperidines as potent orexin (hypocretin) receptor antagonists.

P. Kenny, M. Cameron, T. Kamenecka, 2012, Bioorganic & medicinal chemistry letters.

Selective inhibitor of platelet-activating factor acetylhydrolases 1b2 and 1b3 that impairs cancer cell survival.

Melinda M. Mulvihill, Steven J Brown, J. Chang, 2015, ACS chemical biology.

Synthesis and SAR of 2,4-diaminopyrimidines as potent c-jun N-terminal kinase inhibitors

M. Cameron, Y. Ling, T. Kamenecka, 2012 .

Identification of a Synthetic Agonist for the Orphan Nuclear Receptors ROR α and ROR γ , SR1078

P. Griffin, M. Cameron, W. Roush, 2011 .

Design, Synthesis, and Biological Evaluation of Indole Biphenylcarboxylic Acids as PPARγ Antagonists.

Scott A. Busby, Ruben D. Garcia-Ordonez, P. Griffin, 2015, ACS medicinal chemistry letters.

S 1 P 1 Receptor Modulation with Cyclical Recovery from Lymphopenia Ameliorates Mouse Model of Multiple Sclerosis

P. Gonzalez-Cabrera, H. Rosen, M. Cameron, 2012 .

Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance.

L. Bohn, K. Lovell, M. Cameron, 2022, ACS chemical neuroscience.

D ‑ Amino Acid-Based Protein Arginine Deiminase Inhibitors: Synthesis, Pharmacokinetics, and in Cellulo E ﬃ cacy

A. Chumanevich, L. Hofseth, P. Thompson, 2012 .

Synthesis and biological evaluation of urea derivatives as highly potent and selective rho kinase inhibitors.

P. Lograsso, J. Pocas, Yan Yin, 2013, Journal of medicinal chemistry.

Benzothiazoles as Rho-associated kinase (ROCK-II) inhibitors.

P. Lograsso, S. Schürer, J. Pocas, 2009, Bioorganic & medicinal chemistry letters.

Morphing Natural Product Platensimycin via Heck, Sonogashira, and One-Pot Sonogashira/Cycloaddition Reactions to Produce Antibiotics with In Vivo Activity

M. Cameron, Youchao Deng, Claudia H. Ruiz, 2022, Antibiotics.

Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis.

Mark A. Hall, C. Dang, M. Fallahi, 2014, Cancer research.

Dual Inhibitors of Main Protease (MPro) and Cathepsin L as Potent Antivirals against SARS-CoV2

Jeong Min Lee, C. Schiffer, P. Thompson, 2022, Journal of the American Chemical Society.

Development of a putative Zn2+-chelating but highly selective MMP-13 inhibitor.

Mark S. Sundrud, G. Fields, M. Cameron, 2022, Bioorganic & medicinal chemistry letters.

Cellobiose dehydrogenase-dependent biodegradation of polyacrylate polymers by Phanerochaete chrysosporium

M. Cameron, S. Aust, J. Haselbach, 2000, Environmental science and pollution research international.

Synthesis and Evaluation of Oxyguanidine Analogues of the Cysteine Protease Inhibitor WRR-483 against Cruzain.

J. McKerrow, Yinyan Tang, M. Cameron, 2016, ACS medicinal chemistry letters.

Discovery of Hydrolysis-Resistant Isoindoline N-Acyl Amino Acid Analogues that Stimulate Mitochondrial Respiration.

B. Spiegelman, P. Griffin, D. Nomura, 2018, Journal of medicinal chemistry.

Anti-Diabetic Actions of a Non-Agonist PPARγ Ligand Blocking Cdk5-Mediated Phosphorylation

Scott A. Busby, M. J. Chalmers, Alexander S. Banks, 2011, Nature.

Synthesis and SAR of tetrahydroisoquinolines as Rev-erbα agonists.

D. Kojetin, Subhashish Banerjee, M. Cameron, 2012, Bioorganic & Medicinal Chemistry Letters.

REV-ERBα Regulates TH17 Cell Development and Autoimmunity

D. Kojetin, M. Cameron, S. Mosure, 2018, Cell reports.

Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties.

J. Cleveland, S. Schürer, M. Cameron, 2013, Bioorganic & medicinal chemistry letters.

Rational development of 4-aminopyridyl-based inhibitors targeting Trypanosoma cruzi CYP51 as anti-chagas agents.

J. McKerrow, M. Cameron, W. Roush, 2013, Journal of medicinal chemistry.

4-Aminopyridyl-Based CYP51 Inhibitors as Anti-Trypanosoma cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency

J. Gut, J. McKerrow, M. Cameron, 2014, Journal of medicinal chemistry.

Binding Mode and Potency of N-Indolyloxopyridinyl-4-aminopropanyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51

J. Gut, J. McKerrow, M. Cameron, 2014, Journal of medicinal chemistry.

Gauging reactive metabolites in drug-induced toxicity.

M. Cameron, Marsha R. Eno, M. Eno, 2014, Current medicinal chemistry.

Identification of SR3335 (ML-176): a synthetic RORα selective inverse agonist.

P. Griffin, D. Kojetin, Naresh Kumar, 2011, ACS chemical biology.

Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold–small molecule interactions

Hafeez S Haniff, Ilyas Yildirim, M. Disney, 2020, Nature Chemistry.

Modulators of STAT Transcription Factors for the Targeted Therapy of Cancer (STAT3 Inhibitors)

P. Hodder, Franck Madoux, M. Cameron, 2011 .

S1P1 Receptor Modulation with Cyclical Recovery from Lymphopenia Ameliorates Mouse Model of Multiple Sclerosis

P. Gonzalez-Cabrera, H. Rosen, M. Cameron, 2012, Molecular Pharmacology.

Metabolism considerations for kinase inhibitors in cancer treatment

M. Cameron, Derek R Duckett, D. Duckett, 2010, Expert opinion on drug metabolism & toxicology.

Characterization of Dasatinib and Its Structural Analogs as CYP3A4 Mechanism-Based Inactivators and the Proposed Bioactivation Pathways

M. Cameron, Xiaohai Li, Yuanjun He, 2009, Drug Metabolism and Disposition.

Reprogramming of Protein-Targeted Small-Molecule Medicines to RNA by Ribonuclease Recruitment.

Jessica L. Childs-Disney, M. Disney, Toru Tanaka, 2021, Journal of the American Chemical Society.

Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains

B. H. Miller, J. Marron, Sean Skwerer, 2011, Psychopharmacology.

Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker.

Dmitriy Minond, Peter Hodder, Noel Blake, 2013, Bioorganic & medicinal chemistry.

Design of a small molecule against an oncogenic noncoding RNA

Matthew D Disney, Donald G Phinney, M. Disney, 2016, Proceedings of the National Academy of Sciences.

Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria

Sara R. Jones, J. Rose, L. Bohn, 2016, Science Signaling.

Genetic Regulation of Behavioral and Neuronal Responses to Fluoxetine

B. H. Miller, M. Pletcher, M. Cameron, 2008, Neuropsychopharmacology.

Regulation of Circadian Behavior and Metabolism by Synthetic REV-ERB Agonists

J. Takahashi, T. Hughes, D. Kojetin, 2012, Nature.

Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor.

P. Jänne, Kwok-Kin Wong, N. Gray, 2019, Cancer discovery.

Structure-activity relationships, and drug metabolism and pharmacokinetic properties for indazole piperazine and indazole piperidine inhibitors of ROCK-II.

P. Lograsso, M. Cameron, Claudia H. Ruiz, 2007, Bioorganic & medicinal chemistry letters.

Development of matrix metalloproteinase-13 inhibitors - A structure-activity/structure-property relationship study.

G. Fields, M. Cameron, W. Roush, 2018, Bioorganic & medicinal chemistry.

Small Molecule c-jun-N-terminal Kinase (JNK) Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson's Disease.

Li Lin, P. Lograsso, M. Cameron, 2011, ACS chemical neuroscience.

Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma

C. James, D. Matei, L. Platanias, 2022, Journal of medicinal chemistry.

Biodegradation of superabsorbent polymers in soil

Michael D. Cameron, M. Cameron, S. Aust, 2000, Environmental science and pollution research international.

Bioactivation of the epidermal growth factor receptor inhibitor gefitinib: implications for pulmonary and hepatic toxicities.

M. Cameron, Xiaohai Li, T. Kamenecka, 2009, Chemical research in toxicology.

Potential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosis.

M. Cameron, Xiaohai Li, 2012, Chemical research in toxicology.

Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitors.

M. Cameron, W. Roush, V. Quereda, 2017, Bioorganic & medicinal chemistry letters.

Synthesis and activity of substituted heteroaromatics as positive allosteric modulators for α4β2α5 nicotinic acetylcholine receptors.

P. Kenny, J. Lindstrom, Jingyi Wang, 2014, Bioorganic & medicinal chemistry letters.

Orexin-1 Receptor Mediation of Cocaine Seeking in Male and Female Rats

P. Kenny, M. Cameron, R. See, 2012, Journal of Pharmacology and Experimental Therapeutics.

Crystal structure of h38C2 K99R mutation

Cameron, M. Cameron, W. Roush, 2019 .

Characterization of T-5 N-Oxide Formation as the First Highly Selective Measure of CYP3A5 Activity

G. S. Walker, S. Heyward, M. Cameron, 2014, Drug Metabolism and Disposition.

Discovery of a Highly Selective CYP3A4 Inhibitor Suitable for Reaction Phenotyping Studies and Differentiation of CYP3A4 and CYP3A5

M. Cameron, Xiaohai Li, T. Kamenecka, 2012, Drug Metabolism and Disposition.

Microsoft Word-6984317-file00

M. Cameron, Xiaohai Li, T. Kamenecka, 2012 .

Discovery of a Highly Selective CYP 3 A 4 Inhibitor Suitable for Reaction Phenotyping Studies and Differentiation of CYP 3 A 4 and CYP 3 A 5

M. Cameron, Xiaohai Li, T. Kamenecka, 2012 .

Discovery and optimization of a series of sulfonamide inverse agonists for the retinoic acid receptor-related receptor-α.

Ruben D. Garcia-Ordonez, P. Griffin, Naresh Kumar, 2019, Medicinal chemistry (Shariqah (United Arab Emirates)).

P450 3A-Catalyzed O-Dealkylation of Lapatinib Induces Mitochondrial Stress and Activates Nrf2.

M. Cameron, Marsha R. Eno, M. Eno, 2016, Chemical research in toxicology.

Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains

B. H. Miller, Sean Skwerer, T. Wiltshire, 2011, Psychopharmacology.

Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors.

P. Lograsso, S. Schürer, Yan Yin, 2008, Journal of medicinal chemistry.

Nonmuscle myosin IIB as a therapeutic target for the prevention of relapse to methamphetamine use

G. Rumbaugh, M. Cameron, S. Sillivan, 2016, Molecular Psychiatry.

Identification of a novel non-retinoid pan inverse agonist of the retinoic acid receptors.

Scott A. Busby, P. Griffin, M. Cameron, 2011, ACS chemical biology.

Probing the Complex Binding Modes of the PPARγ Partial Agonist 2-Chloro-N-(3-chloro-4-((5-chlorobenzo[d]thiazol-2-yl)thio)phenyl)-4-(trifluoromethyl)benzenesulfonamide (T2384) to Orthosteric and Allosteric Sites with NMR Spectroscopy.

Ian Mitchelle S. de Vera, T. Hughes, D. Kojetin, 2016, Journal of medicinal chemistry.

Structure-based design of bitopic ligands for the µ-opioid receptor

Samuel T. Slocum, B. Roth, V. Katritch, 2022, Nature.

Successful treatment of mammary hyperplasia in pregnancy with bromocriptine

M. Cameron, C. Lowy, Friedericke Eben, 1993, British journal of obstetrics and gynaecology.

KK-92A, a novel GABAB receptor positive allosteric modulator, attenuates nicotine self-administration and cue-induced nicotine seeking in rats

P. Griffin, Xia Li, M. G. Finn, 2017, Psychopharmacology.

Insular hypocretin transmission regulates nicotine reward

P. Kenny, Qun Lu, M. Cameron, 2008, Proceedings of the National Academy of Sciences.

Cooperative binding of midazolam with testosterone and alpha-naphthoflavone within the CYP3A4 active site: a NMR T1 paramagnetic relaxation study.

M. Cameron, A. Roberts, S. Nelson, 2005, Biochemistry.

DNA-Encoded Library Screening To Inform Design of a Ribonuclease Targeting Chimera (RiboTAC).

M. Disney, A. Adibekian, M. Cameron, 2022, Journal of the American Chemical Society.

Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer.

M. Cameron, W. Roush, Claudia H. Ruiz, 2017, Bioorganic & medicinal chemistry.

Design, synthesis, and evaluation of simple phenol amides as ERRγ agonists.

Ruben D. Garcia-Ordonez, P. Griffin, M. Cameron, 2018, Bioorganic & Medicinal Chemistry Letters.

Addressing the oxamniquine in vitro-in vivo paradox to facilitate a new generation of anti-schistosome treatments

M. Cameron, P. LoVerde, Susan Khan, 2023, International journal for parasitology. Drugs and drug resistance.

Therapeutics , Targets , and Chemical Biology Blocking Lactate Export by Inhibiting the Myc Target MCT 1 Disables Glycolysis and Glutathione Synthesis

Mark A. Hall, C. Dang, M. Fallahi, 2014 .

Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140).

Steven J Brown, M. Urbano, M. Guerrero, 2019, Journal of medicinal chemistry.

Table 1, Assay Summaries

Yongjun Wang, Michael D. Cameron, Becky A. Mercer, 2013 .

R-Configuration of 4-Aminopyridyl-Based Inhibitors of CYP51 Confers Superior Efficacy Against Trypanosoma cruzi.

J. McKerrow, M. Cameron, W. Roush, 2014, ACS medicinal chemistry letters.

N‐Arylsulfonyl Indolines as Retinoic Acid Receptor‐Related Orphan Receptor γ (RORγ) Agonists

Ruben D. Garcia-Ordonez, P. Griffin, M. Cameron, 2016, ChemMedChem.

Small molecule amides as potent ROR-γ selective modulators.

Ruben D. Garcia-Ordonez, P. Griffin, Naresh Kumar, 2013, Bioorganic & medicinal chemistry letters.

Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ.

P. Griffin, Naresh Kumar, M. Cameron, 2010, ACS chemical biology.

Antiobesity Effect of a Small Molecule Repressor of RORγ

Ruben D. Garcia-Ordonez, P. Griffin, D. White, 2015, Molecular Pharmacology.

Exploiting the co-reliance of tumours upon transport of amino acids and lactate: Gln and Tyr conjugates of MCT1 inhibitors.

J. Cleveland, J. Mishra, M. Cameron, 2016, MedChemComm.

Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model

Eric T. Wang, Jonathan L Chen, Walter N. Moss, 2019, Proceedings of the National Academy of Sciences.

Identification of Small Molecule Inhibitors of Wee1 Degradation and Mitotic Entry

S. Schürer, N. Ayad, P. Hodder, 2011 .

Vancomycin C-Terminus Guanidine Modifications and Further Insights into an Added Mechanism of Action Imparted by a Peripheral Structural Modification.

D. Boger, M. Cameron, Zhi-Chen Wu, 2020, ACS infectious diseases.

Table 3, Comparison of Current and Prior ROR Probes

Naresh Kumar, Michael D. Cameron, Becky A. Mercer, 2013 .

Discovery of Potent and Selective Urea-Based ROCK Inhibitors and Their Effects on Intraocular Pressure in Rats.

P. Lograsso, S. Schürer, J. Pocas, 2010, ACS medicinal chemistry letters.

GABAB receptor allosteric modulators exhibit pathway‐dependent and species‐selective activity

P. Griffin, Xia Li, M. G. Finn, 2017, Pharmacology research & perspectives.

Synthesis and SAR of novel isoxazoles as potent c-jun N-terminal kinase (JNK) inhibitors.

P. Lograsso, M. Cameron, Y. Ling, 2014, Bioorganic & medicinal chemistry letters.

Amino acid derived quinazolines as Rock/PKA inhibitors.

P. Lograsso, J. Pocas, M. Cameron, 2013, Bioorganic & medicinal chemistry letters.

Potent, Selective and Cell Penetrant Inhibitors of SF-1 by Functional Ultra-High-Throughput Screening

P. Griffin, P. Hodder, Franck Madoux, 2008, Molecular Pharmacology.

Binding Mode and Potency of N-Indolyloxopyridinyl-4-aminopropanyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51

J. Gut, J. McKerrow, M. Cameron, 2014, Journal of Medicinal Chemistry.

ML311: A Small Molecule that Potently and Selectively Disrupts the Protein-Protein Interaction of Mcl-1 and Bim: A Probe for Studying Lymphoid Tumorigenesis

T. Spicer, M. Cardone, J. Mishra, 2013 .

Basolateral Amygdala Corticotrophin Releasing Factor Receptor 2 Interacts with Nonmuscle Myosin II to Destabilize Memory

G. Rumbaugh, M. Cameron, Courtney A. Miller, 2023, bioRxiv.

Identification of free radicals produced during phacoemulsification

M. Cameron, S. Aust, J. Poyer, 2001, Journal of cataract and refractive surgery.

REV-ERBα Regulates TH17 Cell Development and Autoimmunity

D. Kojetin, M. Cameron, S. Mosure, 2018, Cell reports.

Potent suppression of HIV-1 cell attachment by Kudzu root extract

H. Choe, M. Stevenson, M. Cameron, 2018, Retrovirology.